Position in HLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,380
+$640 QoQ
Shares Held
148
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#584
of 639 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $29,756 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
166 | $11,928 | |
| 2 | VTRS |
Viatris Inc
|
504 | $8,003 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
251 | $4,023 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
76 | $1,928 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
207 | $1,734 | |
| 6 | HLN |
Haleon plc
This page
|
148 | $1,380 | |
| 7 | SHPH |
Shuttle Pharmaceuticals Holdings, Inc.
|
120 | $390 | |
| 8 | ELTP |
Elite Pharmaceuticals Inc /Nv/
|
1,000 | $370 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,380 | 148 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $740 | 74 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $748 | 74 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $663 | 74 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||